The WP4 working group, led by the researcher at the Aragonese Institute of Health Sciences (IACS) Enrique Bernal, has coordinated the work of 28 socio-sanitary experts from 14 different countries (Austria, Germany Belgium, Finland, France, Greece,Ireland, Italy, Norway, Portugal, Romania, Slovenia, Spain, and the United Kingdom) that have finally completed a total of 9 criteria and 39 categories for the evaluation of diabetes practices.
The design of the practice, ethical considerations, evaluation, sustainability and scalability and patient empowerment are some of the 9 criteria with which practices in diabetes will be evaluated.
These criteria, as well as their corresponding categories, are included in the knowledge platform of the European Joint Action Chrodis (Chrodis Platform), which will be open to the public in January 2017.
In addition, the platform will include an online service with expert consultants for the development and implementation, evaluation and transfer of good practices in chronic diseases.He will also collect a digital library with contents of interest in chronicity, the Aragon government has reported in a press release.
Joint Action of the EU
Chrodis is a joint action of the European Union, in which 26 Member States participate, which seeks the exchange of good practices in chronic diseases, as well as promoting healthy aging throughout the life cycle.
The Government of Spain, through the Ministry of Health, Social Services and Equality and the Carlos III Institute, coordinates the Chrodis project, which has the co -financing of the General Directorate of Health of the European Commission since its implementation in 2014.
The IACS, a center assigned to the Ministry of Health of the Government of Aragon, assumed the leadership of the WP4 working group in which this project is framed.
The final objective is that governments, researchers, patients, caregivers, professionals, medical and social organizations and public opinion in general can evaluate and recognize the best practices, interventions or policies on diabetes;and eventually facilitate its transfer to other European health contexts.
These results, together with those already obtained in the working groups dedicated to multimorbility, health promotion and empowerment of the patient, are available here.
